Sarah Scollon, M.S., C.G.C. Photo

Sarah Scollon, M.S., C.G.C.

Assistant Professor
Baylor College of Medicine

Presentations

Past
Navigating Germline Implications of Clinical Tumor Testing
Pediatric Hematology-Oncology Research Seminar Series
1 hr
Credit
Past
QA Presentations (February 10, 2021)
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Anaplastic Lymphoma Kinase Fusion
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Molecular Diagnosis of Low-Grade Brain Tumors
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Acute Myeloid Leukemia with a Germline CEBPA Variant
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
"Retroperitoneal Tumor with NTRK1 Fusion in a Toddler" and "Pleuropulmonary Blastoma with a DICER1 Mutation in a Toddler"
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Genomic Alterations Informing Treatment of Vascular Tumors
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Theme: Results from the Molecular Characterization Initiative (MCI)
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
"A Teenager with a High-Grade Optic Pathway Tumor with a High Tumor Mutation Burden" and "A School-Age Child with High-Grade Glioma with a High Tumor Mutation Burden"
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
QA Presentations (May 12, 2021)
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit

Planning Committee Member

Past
QA Presentations (May 12, 2021)
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
"A Teenager with a High-Grade Optic Pathway Tumor with a High Tumor Mutation Burden" and "A School-Age Child with High-Grade Glioma with a High Tumor Mutation Burden"
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Acute Myeloid Leukemia with a Germline CEBPA Variant
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
QA Presentations (February 10, 2021)
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
QA Presentations (March 10, 2021)
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Management Consideration for a Toddler with Li Fraumeni Syndrome and Rhabdomyosarcoma
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Genomic Alterations Informing Treatment of Vascular Tumors
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Management of Thyroid Cancer in Children
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Molecular Diagnosis of Low-Grade Brain Tumors
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Anaplastic Lymphoma Kinase Fusion
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Two Cases of Anaplastic Ganglioglioma with Distinct Molecular Drivers
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Quality Assurance Presentation: Complexities of CEBPA in Pediatric Acute Myeloid Leukemia
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Theme: Results from the Molecular Characterization Initiative (MCI)
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Mesenchymal Tumors with CREB::CREM Fusion
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
CIC-Rearranged Sarcoma
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
"Retroperitoneal Tumor with NTRK1 Fusion in a Toddler" and "Pleuropulmonary Blastoma with a DICER1 Mutation in a Toddler"
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Past
Pediatric Acute Leukemia with ETV6 Alterations
Texas Children's Cancer Center Genomics Tumor Board Series
1 hr
Credit
Get accredited CME directly to your inbox monthly
Subscribe